Nevertheless, there is currently no proof estimating the effectiveness of the 14-3-3 Eta protein biomarker in JIA patients, either in identifying the disease’s activity or its role in identifying uveitis risk in JIA, and RA patients. Here, YWHAH is linked to uveitis.